Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • JnJ CEO declines to...

    JnJ CEO declines to appear at US congressional hearing on carcinogen in baby powder

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-12-10T09:15:58+05:30  |  Updated On 10 Dec 2019 9:15 AM IST

    JnJ spokesman Ernie Knewitz said that the subcommittee had rejected the company's offers to send a talc testing expert or a JnJ executive in charge of consumer products.


    New Delhi: Johnson & Johnson Chief Executive Officer Alex Gorsky has declined to appear at a U.S. congressional hearing set for Tuesday on the safety of the company's Baby Powder and other talc-based cosmetics.


    In an announcement, the House of Representatives Subcommittee on Economic and Consumer Policy said that its efforts to persuade Gorsky to testify included "repeated attempts to accommodate the company" over nearly a month.


    Democrat Raja Krishnamoorthi, chairman of the House panel investigating concerns about cancer-causing asbestos in cosmetic talc and powders, said he was disappointed as Gorsky turned down the invitation.


    "Mr Gorsky refuses to speak to the Subcommittee under oath, yet he has not refrained from making multiple public comments on the topic," Krishnamoorthi said in a statement.


    JnJ spokesman Ernie Knewitz said that the subcommittee had rejected the company's offers to send a talc testing expert or a JnJ executive in charge of consumer products.


    Gorsky "is not, as we have repeatedly told the Subcommittee, an expert in the stated subject of the hearing," Knewitz said. "We have respectfully declined the invitation for our CEO to testify."


    Knewitz said that the composition of the hearing, which includes two experts who have testified for plaintiffs against J&J, also factored into the company's decision.


    Gorsky has played a lead role in J&J's efforts to reassure consumers and investors that its talc powders are safe and asbestos-free. Last year, he issued a statement vouching for the safety of the products after a jury issued a $4.69 billion verdict in favour of 22 women who sued over allegations their ovarian cancers were caused by J&J powders.


    Gorsky appeared on CNBC's "Mad Money with Jim Cramer" and in a video posted on J&J's website to rebut a December 2018 Reuters reported that the company knew for decades about the presence of small amounts of asbestos in its talc and powders.


    “Since tests for asbestos in talc were first developed, J&J’s Baby Powder has never contained asbestos,” Gorsky said in the video.


    Read Also: Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia


    In October, Gorsky testified in a deposit in a lawsuit filed by an Indiana man, saying, "We unequivocally believe that our talc and our baby powder does not contain asbestos." JnJ faces more than 16,000 similar lawsuits.


    Concerns over asbestos in talc cosmetics have grown in recent months as the U.S. Food and Drug Administration announced that the carcinogen had been found in several products, including a bottle of Baby Powder.


    J&J said it recalled 33,000 bottles of Baby Powder “out of an abundance of caution.” Later, J&J said labs it hired found no asbestos - other than some contamination it blamed on an air conditioner - in samples from the same Baby Powder bottle and its production lot.


    The FDA has said it stands by its finding.


    Chief executives of companies embroiled in controversies routinely comply with lawmakers’ invitations to testify.


    In recent months, the CEOs of Boeing (BA.N) and Facebook (FB.O) have appeared before congressional committees to answer questions about how their companies were safeguarding consumers.


    Charles M. Elson, director of the John L. Weinberg Center for Corporate Governance at the University of Delaware, said CEOs have a responsibility to go to Washington when Congress calls, just like other citizens.


    But Elson said Gorsky’s pass was understandable. He said the CEO and his advisers probably figured that the downside was greater to testifying than not.


    “It’s being invited in for a punch in the nose,” Elson said. For Gorsky, “nothing good will come out of it.”


    Read Also: No asbestos found in baby powder test, says Johnson and Johnson

    Alex Gorskyasbestosbaby powderbaby powder testchief executive officerJnJjnj talc testJohnsonJohnson & JohnsonJohnson Baby PowderUSFDA
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok